Effects of hypertonic (7%) saline on brain injury in experimental Escherichia coli meningitis

Journal of Korean Medical Science

Volumn 20, Issue 5, 2005, Pages 870-876

  Chang, Won Choi ^a   Jong, Hee Hwang ^a   Yun, Sil Chang ^a   Won, Soon Park ^a   Beyong, Il Kim ^b   Choi, Jung Hwan ^b   Lee, Munhyang ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Samsung Medical Center   (South Korea)

Author keywords

Animal Experimentation; Escherichia coli; Meningitis, Bacterial; Saline Solution, Hypertonic

Indexed keywords

EID: 27744579092     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.5.870     Document Type: Article

References (37)

1. De Louvois J. Acute bacterial meningitis in the newborn. J Antimicrob Chemother 1994; 34 (Suppl): 61-73.
2. Nau R, Brack W. Neuronal injury in bacterial meningitis: mechanisms and implications for therapy. Trends Neurosci 2002; 25: 38-45.
3. Park WS, Chang YS, Lee M. Effect of induced hyperglycemia on brain cell membrane function and energy metabolism during the early phase of experimental meningitis in newborn piglets. Brain Res 1998; 798: 195-203.
4. Park WS, Chang YS. Effects of decreased cerebral perfusion pressure on cerebral hemodynamics, brain cell membrane function and energy metabolism during the early phase of experimental Escherichia coli meningitis in the newborn piglet. J Korean Med Sci 2000; 15: 203-10.
5. Tureen JH. Cerebral blood flow and metabolism in experimental meningitis. Pediatr Infect Dis J 1989; 8: 917-8.
6. Kreimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand 2002; 46: 625-38.
7. Tollofsrud S, Kramer GC. Intra-operative use of hypertonic solutions. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin Heidelberg 2000: 476-85.
8. Thomas SJ, Kramer GC, Herndon DN. Burns: military options and tactical solutions. J Trauma 2003; 54 (Suppl 5): S207-18.
9. Oliveira RP, Weingartner R, Ribas EO, Moraes RS, Friedman G. Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis. Intensive Care Med 2002; 28: 1574-81.
10. Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004; 10: 126-31.
11. Onarheim H. Fluid shifts following 7% hypertonic saline (2400 mosmol/L) infusion. Shock 1995; 3: 350-4.
12. Elgjo GI, Mathew BP, Poli de Figueiredo LF, Schenarts PJ, Horton JW, Dubick MA, Kramer GC. Resuscitation with hypertonic saline dextran improves cardiac function in vivo and ex vivo after burn injury in sheep. Shock 1998; 9: 375-83.
13. Behrman SW, Fabian TC, Kudsk KA, Proctor KG. Microcirculatory flow changes after initial resuscitation of hemorrhagic shock with 7.5% hypertonic saline/6% dextran 70. J Trauma 1991; 31: 589-98.
14. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000; 28: 3301-13.
15. Schmoker JD, Zhuang J, Shackford SR. Hypertonic fluid resuscitation improves cerebral oxygen delivery and reduces intracranial pressure after hemorrhagic shock. J Trauma 1991; 31: 1607-13.
16. Angle N, Cabello-Passini R, Hoyt DB, Loomis WH, Shreve A, Namiki S, Junger WG. Hypertonic saline infusion: can it regulate human neutrophil function? Shock 2000; 14: 503-8.
17. Pingle SC, Sanchez JF, Hallam DM, Williamson AL, Maggirwar SB, Ramkumar V. Hypertonicity inhibits lipopolysaccharide-induced nitric oxide synthase expression in smooth muscle cells by inhibiting nuclear factor kappaB. Mol Pharmacol 2003; 63: 1238-47.
18. Ciesla DJ, Moore EE, Musters RJ, Biffl WL, Silliman CA. Hypertonic saline alteration of the PMN cytoskeleton: implications for signal transduction and the cytotoxic response. J Trauma 2001; 50: 206-12.
19. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000; 28: 1136-43.
20. Harik SI, Doull GH, Dick AP. Specific ouabain binding to brain microvessels and choroid plexus. J Cereb Blood Flow Metab 1985; 5: 156-60.
21. +-ATPase in cortical brain slices incubated in normal Krebs-Ringer phosphate medium at 1 and at 10 atm oxygen pressures. J Neurochem 1981; 36: 333-5.
22. Recknagel RO, Glende EA Jr. Spectrophotometric detection of lipid conjugated dienes. Methods Enzymol 1984; 105: 331-7.
23. Lamprecht WA, Stein P, Heinz F. Creatine phosphate. In: Bergmeyer HU (ed) Methods of enzymatic analysis. New York 1974: 1771-81.
24. Powers KA, Woo J, Khadaroo RG, Papia G, Kapus A, Rotstein OD. Hypertonic resuscitation of hemorrhagic shock upregulates the antiinflammatory response by alveolar macrophages. Surgery 2003; 134: 312-8.
25. Park WS, Chang YS, Lee M. Effect of α-phenyl-n-tert-butylnitrone on brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. J Neurochem 2000; 74: 763-9.
26. Park WS, Chang YS, Shim JW, Kim MJ, Ko SY, Kim SS, Hwang JH, Choi CW, Lee M. Effects of dopamine infusion on cerebral blood flow, brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. J Korean Med Sci 2003; 18: 869-75.
27. Tureen JH, Tauber MG, Sande MA. Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis. J Clin Invest 1992; 89: 947-53.
28. Täuber MG, Moser B. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis 1999; 28: 1-12.
29. Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys 1986; 247: 1-11.
30. Yeagle PL. Lipid regulation of cell membrane structure and function. FASEBJ 1989; J 3: 1833-42.
31. Lees GJ. Inhibition of sodium-potasslum-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology. Brain Res Rev 1991; 16: 283-300.
32. Park WS, Chang YS, Lee M. Effect of hypothermia on brain cell membrane function and energy metabolism in experimental Escherichia coli meningitis in the newborn piglet. Neurochem Res 2001; 26: 369-74.
33. Park WS, Chang YS, Lee M. 7-Nitroindazole, but not aminoguanidine, attenuates the acute inflammatory responses and brain injury during the early phase of Escherichia coli meningitis in the newborn piglet. Biol Neonate 2001; 80: 53-9.
34. Park WS, Chang YS, Ko SY, Kang MJ, Han JM, Lee M. Efficacy of anti-tumor necrosis factor-alpha antibody as an adjunctive therapy in experimental Escherichia coli meningitis in the newborn piglet. Biol Neonate 1999; 75: 377-87.
35. Dobbing J, Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979; 3: 79-83.
36. Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, Fischer GW. Early-onset group B streptococcal sepsis: a current assessment. J Pediatr 1992; 121: 428-33.
37. Park WS, Chang YS, Ko SY, Kang MJ, Han JM, Lee M. Effects of microbial invasion on cerebral hemodynamics and oxygenation monitored by near infrared spectroscopy in experimental Escherichia coli meningitis in the newborn piglet. Neurol Res 1999; 21: 391-8.